Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: CYTARABINE, . Treffer: 22

2020

Hatzl, S; Perfler, B; Wurm, S; Uhl, B; Quehenberger, F; Ebner, S; Troppmair, J; Reinisch, A; Wölfler, A; Sill, H; Zebisch, A Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia.
Cancers (Basel). 2020; 12(2): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2018

Hatzl, S; Uhl, B; Hinterramskogler, M; Leber, S; Eisner, F; Haring, M; Jud, P Acute myeloid leukemia with severe coagulation disorder and concomitant central nervous system bleeding - a clinical diagnostic case report.
EJIFCC. 2018; 29(2): 146-151. (- Case Report) [OPEN ACCESS]
PubMed PUBMED Central

 

2017

Chao, MP; Gentles, AJ; Chatterjee, S; Lan, F; Reinisch, A; Corces, MR; Xavy, S; Shen, J; Haag, D; Chanda, S; Sinha, R; Morganti, RM; Nishimura, T; Ameen, M; Wu, H; Wernig, M; Wu, JC; Majeti, R Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease.
Cell Stem Cell. 2017; 20(3): 329-344. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ugurel, S; Loquai, C; Terheyden, P; Schadendorf, D; Richtig, E; Utikal, J; Gutzmer, R; Rass, K; Sunderkotter, C; Stein, A; Fluck, M; Kaatz, M; Trefzer, U; Kahler, K; Stadler, R; Berking, C; Holler, C; Kerschke, L; Edler, L; Kopp-Schneider, A; Becker, JC Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial
ONCOTARGET. 2017; 8(44): 76029-76043. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Bainschab, A; Quehenberger, F; Greinix, HT; Krause, R; Wölfler, A; Sill, H; Zebisch, A Infections in patients with acute myeloid leukemia treated with low-intensity therapeutic regimens: Risk factors and efficacy of antibiotic prophylaxis.
Leuk Res. 2016; 42(3):47-51
Web of Science PubMed FullText FullText_MUG

 

2014

Valentin, A; Troppan, K; Pfeilstöcker, M; Nösslinger, T; Linkesch, W; Neumeister, P Safety and tolerability of intrathecal liposomal cytarabine as central nervous system prophylaxis in patients with acute lymphoblastic leukemia.
Leuk Lymphoma. 2014; 55(8):1739-1742
Web of Science PubMed FullText FullText_MUG

 

2011

Schwarzenberg, J; Radu, CG; Benz, M; Fueger, B; Tran, AQ; Phelps, ME; Witte, ON; Satyamurthy, N; Czernin, J; Schiepers, C Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway.
Eur J Nucl Med Mol Imaging. 2011; 38(4):711-721 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2010

Creutzig, U; Zimmermann, M; Dworzak, M; Urban, C; Henze, G; Kremens, B; Lakomek, M; Bourquin, JP; Stary, J; Reinhardt, D Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses.
Br J Haematol. 2010; 149(3): 399-409. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2009

Benesch, M; Siegler, N; von Hoff, K; Lassay, L; Kropshofer, G; Müller, H; Sommer, C; Rutkowski, S; Fleischhack, G; Urban, C Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study.
Anticancer Drugs. 2009; 20(9): 794-799.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2008

Benesch, M; Urban, C Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developments.
Expert Opin Pharmacother. 2008; 9(2): 301-309.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Moricke, A; Reiter, A; Zimmermann, M; Gadner, H; Stanulla, M; Dordelmann, M; Loning, L; Beier, R; Ludwig, WD; Ratei, R; Harbott, J; Boos, J; Mann, G; Niggli, F; Feldges, A; Henze, G; Welte, K; Beck, JD; Klingebiel, T; Niemeyer, C; Zintl, F; Bode, U; Urban, C; Wehinger, H; Niethammer, D; Riehm, H; Schrappe, M Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
Blood. 2008; 111(9): 4477-4489. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Sommer, C; Lackner, H; Benesch, M; Sovinz, P; Schwinger, W; Moser, A; Bergloeff, J; Gruber, A; Urban, C Neuroophthalmological side effects following intrathecal administration of liposomal cytarabine for central nervous system prophylaxis in three adolescents with acute myeloid leukaemia.
Ann Hematol. 2008; 87(11): 887-890. (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2007

Benesch, M; Sovinz, P; Krammer, B; Lackner, H; Mann, G; Schwinger, W; Gadner, H; Urban, C Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis.
J Pediatr Hematol Oncol. 2007; 29(4): 222-226. (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2006

Schmid, C; Schleuning, M; Schwerdtfeger, R; Hertenstein, B; Mischak-Weissinger, E; Bunjes, D; Harsdorf, SV; Scheid, C; Holtick, U; Greinix, H; Keil, F; Schneider, B; Sandherr, M; Bug, G; Tischer, J; Ledderose, G; Hallek, M; Hiddemann, W; Kolb, HJ Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation.
Blood. 2006; 108(3): 1092-1099.
Web of Science PubMed FullText FullText_MUG

 

2005

Nachbaur, D; Greinix, HT; Koller, E; Krieger, O; Linkesch, W; Kasparu, H; Pober, M; Hinterberger, W; Hausmaninger, H; Heistinger, M; Ulsperger, E; Karlhuber, S; Schwinger, W; Lindner, B Long-term results of autologous stem cell transplantation for Hodgkin's disease (HD) and low-/intermediate-grade B non-Hodgkin's lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR).
Ann Hematol. 2005; 84(7):462-473
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2003

Kühr, T; Burgstaller, S; Apfelbeck, U; Linkesch, W; Seewann, H; Fridrik, M; Michlmayr, G; Krieger, O; Lutz, D; Lin, W; Pont, J; Köck, L; Abbrederis, K; Baldinger, C; Buder, R; Geissler, D; Hausmaninger, H; Lang, A; Zabernigg, A; Duba, C; Hilbe, W; Eisterer, W; Fiegl, M; Greil, R; Gastl, G; Thaler, J; Austrian CML Study Group A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).
Leuk Res. 2003; 27(5):405-411
Web of Science PubMed FullText FullText_MUG

 

2001

Benesch, M; Lackner, H; Moser, A; Kerbl, R; Schwinger, W; Oberbauer, R; Eder, HG; Mayer, R; Wiegele, K; Urban, C Outcome and long-term side effects after synchronous radiochemotherapy for childhood brain stem gliomas.
Pediatr Neurosurg. 2001; 35(4):173-180
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2000

Kortmann, RD; Kühl, J; Timmermann, B; Mittler, U; Urban, C; Budach, V; Richter, E; Willich, N; Flentje, M; Berthold, F; Slavc, I; Wolff, J; Meisner, C; Wiestler, O; Sörensen, N; Warmuth-Metz, M; Bamberg, M Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
INT J RADIAT ONCOL BIOL PHYS. 2000; 46(2): 269-279.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kühr, T; Eisterer, W; Apfelbeck, U; Linkesch, W; Bechter, O; Zabernigg, A; Geissler, K; Barbieri, G; Duba, C; Gastl, G; Thaler, J Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot study.
Leuk Res. 2000; 24(7):583-587
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1998

Urban, C; Benesch, M; Pakisch, B; Lackner, H; Kerbl, R; Schwinger, W; Oberbauer, R Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.
J Neurooncol. 1998; 39(1):71-80
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1989

Linkesch, W; Michlmayr, G; Gerhartz, H; Illinger, H; König, H; Düllmann, J; Keilhauer, R; Moldrzyk, D Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German results.
Onkologie. 1989; 12(1):8-10
Web of Science PubMed Google Scholar

 

1988

Urban, C; Schwingshandl, J; Slavc, I; Gamillscheg, A; Hauer, C; Schmid, G; Kaulfersch, W; Borkenstein, M Endocrine function after bone marrow transplantation without the use of preparative total body irradiation.
Bone Marrow Transplant. 1988; 3(4):291-296
Web of Science PubMed Google Scholar

 

© Med Uni Graz Impressum